These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 30226898)

  • 1. Triggered radiosensitizer delivery using thermosensitive liposomes and hyperthermia improves efficacy of radiotherapy: An in vitro proof of concept study.
    Besse HC; Bos C; Zandvliet MMJM; van der Wurff-Jacobs K; Moonen CTW; Deckers R
    PLoS One; 2018; 13(9):e0204063. PubMed ID: 30226898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperthermia-triggered release of hypoxic cell radiosensitizers from temperature-sensitive liposomes improves radiotherapy efficacy in vitro.
    Sadeghi N; Kok RJ; Bos C; Zandvliet M; Geerts WJC; Storm G; Moonen CTW; Lammers T; Deckers R
    Nanotechnology; 2019 Jun; 30(26):264001. PubMed ID: 30836341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and optimization of idarubicin thermosensitive liposomes provides ultrafast triggered release at mild hyperthermia and improves tumor response.
    Lu T; Lokerse WJM; Seynhaeve ALB; Koning GA; Ten Hagen TLM
    J Control Release; 2015 Dec; 220(Pt A):425-437. PubMed ID: 26541464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug development of lyso-thermosensitive liposomal doxorubicin: Combining hyperthermia and thermosensitive drug delivery.
    Borys N; Dewhirst MW
    Adv Drug Deliv Rev; 2021 Nov; 178():113985. PubMed ID: 34555486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.
    Li L; ten Hagen TL; Hossann M; Süss R; van Rhoon GC; Eggermont AM; Haemmerich D; Koning GA
    J Control Release; 2013 Jun; 168(2):142-50. PubMed ID: 23524188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Method of hyperthermia and tumor size influence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumors.
    Willerding L; Limmer S; Hossann M; Zengerle A; Wachholz K; Ten Hagen TL; Koning GA; Sroka R; Lindner LH; Peller M
    J Control Release; 2016 Jan; 222():47-55. PubMed ID: 26658073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of SR-4233 with hyperthermia and radiation in the FSaIIC murine fibrosarcoma tumor system in vitro and in vivo.
    Herman TS; Teicher BA; Coleman CN
    Cancer Res; 1990 Aug; 50(16):5055-9. PubMed ID: 2379171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced drug delivery in rabbit VX2 tumours using thermosensitive liposomes and MRI-controlled focused ultrasound hyperthermia.
    Staruch RM; Ganguly M; Tannock IF; Hynynen K; Chopra R
    Int J Hyperthermia; 2012; 28(8):776-87. PubMed ID: 23153219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulated Electro-Hyperthermia Accelerates Tumor Delivery and Improves Anticancer Activity of Doxorubicin Encapsulated in Lyso-Thermosensitive Liposomes in 4T1-Tumor-Bearing Mice.
    Aloss K; Bokhari SMZ; Leroy Viana PH; Giunashvili N; Schvarcz CA; Szénási G; Bócsi D; Koós Z; Storm G; Miklós Z; Benyó Z; Hamar P
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy.
    Ning S; Macleod K; Abra RM; Huang AH; Hahn GM
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):827-34. PubMed ID: 8040030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of environmental conditions (pH, oxygenation, and temperature) on misonidazole cytotoxicity and radiosensitization in vitro and in vivo in FSaIIC fibrosarcoma.
    Holden SA; Teicher BA; Herman TS
    Int J Radiat Oncol Biol Phys; 1991 May; 20(5):1031-8. PubMed ID: 2022503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surrogate MRI markers for hyperthermia-induced release of doxorubicin from thermosensitive liposomes in tumors.
    Peller M; Willerding L; Limmer S; Hossann M; Dietrich O; Ingrisch M; Sroka R; Lindner LH
    J Control Release; 2016 Sep; 237():138-46. PubMed ID: 27364227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleaved Mapping of Temperature and Longitudinal Relaxation Rate to Monitor Drug Delivery During Magnetic Resonance-Guided High-Intensity Focused Ultrasound-Induced Hyperthermia.
    Kneepkens E; Heijman E; Keupp J; Weiss S; Nicolay K; Grüll H
    Invest Radiol; 2017 Oct; 52(10):620-630. PubMed ID: 28598900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, Tissue Distribution and Therapeutic Effect of Cationic Thermosensitive Liposomal Doxorubicin Upon Mild Hyperthermia.
    Dicheva BM; Seynhaeve AL; Soulie T; Eggermont AM; Ten Hagen TL; Koning GA
    Pharm Res; 2016 Mar; 33(3):627-38. PubMed ID: 26518763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oxygenation, pH and hyperthermia on RSU-1069 in vitro and in vivo with radiation in the FSaIIC murine fibrosarcoma.
    Teicher BA; Herman TS; Holden SA; Rudolph MB
    Cancer Lett; 1991 Aug; 59(2):109-17. PubMed ID: 1884367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo.
    Wang C; Wang X; Zhong T; Zhao Y; Zhang WQ; Ren W; Huang D; Zhang S; Guo Y; Yao X; Tang YQ; Zhang X; Zhang Q
    Int J Nanomedicine; 2015; 10():2229-48. PubMed ID: 25834435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focused Ultrasound Hyperthermia Mediated Drug Delivery Using Thermosensitive Liposomes and Visualized With
    Santos MA; Goertz DE; Hynynen K
    Theranostics; 2017; 7(10):2718-2731. PubMed ID: 28819458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lyso-thermosensitive liposomal doxorubicin for treatment of bladder cancer.
    Mikhail AS; Negussie AH; Pritchard WF; Haemmerich D; Woods D; Bakhutashvili I; Esparza-Trujillo J; Brancato SJ; Karanian J; Agarwal PK; Wood BJ
    Int J Hyperthermia; 2017 Nov; 33(7):733-740. PubMed ID: 28540814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat-activated drug delivery increases tumor accumulation of synergistic chemotherapies.
    Dunne M; Epp-Ducharme B; Sofias AM; Regenold M; Dubins DN; Allen C
    J Control Release; 2019 Aug; 308():197-208. PubMed ID: 31195059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial protocol for TARDOX: a phase I study to investigate the feasibility of targeted release of lyso-thermosensitive liposomal doxorubicin (ThermoDox®) using focused ultrasound in patients with liver tumours.
    Lyon PC; Griffiths LF; Lee J; Chung D; Carlisle R; Wu F; Middleton MR; Gleeson FV; Coussios CC
    J Ther Ultrasound; 2017; 5():28. PubMed ID: 29118984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.